Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip

ClinicalTrials.gov ID: NCT00541489

Public ClinicalTrials.gov record NCT00541489. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 1:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To study the efficacy and safety of Naproxcinod vs. Placebo and Naproxen in the treatment of signs and symptoms of Osteoarthritis.

Study identification

NCT ID
NCT00541489
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
NicOx
Industry
Enrollment
800 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2007
Primary completion
Aug 31, 2008
Completion
Not listed
Last update posted
Feb 19, 2009

Started 2007

United States locations

U.S. sites
36
U.S. states
18
U.S. cities
36
Facility City State ZIP Site status
Not listed Mobile Alabama 36608
Not listed Montgomery Alabama 36106
Not listed Tuscaloosa Alabama 35406
Not listed Chandler Arizona 85224
Not listed Mesa Arizona 85213
Not listed Phoenix Arizona 85016
Not listed Fair Oaks California 95628
Not listed San Diego California 92120
Not listed Santa Barbara California 93111
Not listed Northglenn Colorado 80234
Not listed Coral Gables Florida 33134
Not listed Daytona Beach Florida 32117
Not listed DeLand Florida 32720
Not listed Fort Meyers Florida 33916
Not listed Jupiter Florida 33458
Not listed Louisville Kentucky 40291
Not listed Peabody Massachusetts 01960
Not listed Kalamazoo Michigan 49009
Not listed Saginaw Michigan 48602
Not listed Berlin New Jersey 08009
Not listed Dover New Jersey 07801
Not listed Rochester New York 14609
Not listed Cincinnati Ohio 45224
Not listed Cleveland Ohio 44122
Not listed Franklin Ohio 45005
Not listed Bethany Oklahoma 73008
Not listed Duncansville Pennsylvania 16635
Not listed Penndel Pennsylvania 19047
Not listed Warwick Rhode Island 02886
Not listed Anderson South Carolina 29621
Not listed Columbia South Carolina 29204
Not listed Kingsport Tennessee 37660
Not listed Austin Texas 78705
Not listed Nederland Texas 77627
Not listed San Antonio Texas 78217
Not listed Newport News Virginia 23606

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00541489, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 19, 2009 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00541489 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →